34.236.192.4
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Continuing Medical Education

Transitioning Treatment in Diabetic Retinopathy

Posted on September 9, 2019

Intravitreal therapy has rapidly evolved to become a mainstay of treatment for many retinal diseases, offering delayed or arrested disease progression and the possibility of regaining lost vision for many patients. Notable among the diseases that have been found to respond well to intravitreal therapy are age-related macular degeneration, retinal vein occlusion, diabetic macular edema, and, more recently, diabetic retinopathy (DR). The discovery that intravitreal therapy can be effective in treating DR has spurred further research to explore the outcomes of intravitreal treatment regimens. In this continuing medical education activity, expert physicians will examine effective ways to diagnose and treat DR.

-Advertisement-
Related Articles
Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapies: Updates in Diabetic Eye Diseases, Retinal Vein Occlusion and Age-Related Macular Degeneration – A Four-Part Series
Nov 12, 2020
October 19: Practical Management of Inherited Retinal Disorders
May 05, 2020
Dry Eye Disease Management for Improving Patient Outcomes
Oct 17, 2019
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-